ICI monotherapies induced the expansion of different tumor-infiltrating T cells (TILs), i.e., PD-1 blockade expanded exhausted-like CD8+ CTLs, whereas CTLA-4 blockade expanded both ICOS+ Th1-like CD4 effectors and exhausted CD8+ CTLs. The gene discussed is CD4; the disease is neoplasm.